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Abstract
Objective:  To  describe  the  characteristics  of  children  aged  0--14  years  diagnosed  with  diabetic
ketoacidosis  and  compare  the  following  outcomes  between  children  with  prior  diagnosis  of  type
1 diabetes  mellitus  and  children  without  prior  diagnosis  of  type  1  diabetes  mellitus  length  of
hospital stay,  severity  on  admission,  insulin  dosage,  time  of  continuous  insulin  use,  volume  of
ﬂuids infused  during  treatment,  and  complications.
Methods:  A  retrospective  descriptive  study  with  review  of  medical  records  of  patients  admitted
to the  pediatric  intensive  care  unit  of  a  referral  hospital  from  June  2013  to  July  2015.  The  fol-
lowing data  regarding  52  admissions  were  analyzed:  age,  sex,  weight,  body  surface  area,  signs,
symptoms  and  severity  on  admission,  blood  gas,  blood  glucose,  glycated  hemoglobin,  serum
osmolarity,  and  index  of  mortality.  The  insulin  dosage,  time  of  continuous  insulin  use,  volume
administered  in  the  expansion  phase  and  in  the  ﬁrst  24  h,  length  of  stay,  and  complications
such as  electrolyte  disturbances,  hypoglycemia,  cerebral  edema,  and  death  were  compared
between the  two  groups.
Results:  Patients  without  a  previous  diagnosis  of  DM1  were  younger  at  admission,  with  mean
age of  8.4  years  (p  <  0.01),  reported  more  nausea  or  vomiting,  polydipsia  and  polyuria,  and
showed more  weight  loss  (p  <  0.01).  This  study  also  observed  a  higher  prevalence  of  hypokalemia
(p <  0.01)  and  longer  hospital  stay  in  this  group.
Conclusions:  No  differences  in  severity  between  groups  were  observed.  The  study  showed  that
children without  prior  diagnosis  of  type  1  diabetes  mellitus  were  younger  at  admission,  had
more hypokalemia  during  the  course  of  treatment,  and  had  greater  length  of  hospital  stay.
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Cetoacidose  Diabética  em  uma  Unidade  de  Terapia  Intensiva  Pediátrica
Resumo
Objetivo:  Descrever  as  características  de  pacientes  de  zero  a  14  anos  admitidos  com  diagnóstico
de Cetoacidose  Diabética  e  comparar  desfechos  entre  os  pacientes  com  diabete  melito  tipo  1
prévio e  aqueles  sem  diabete  melito  tipo  1  prévio:  tempo  de  internac¸ão,  gravidade  na  admissão,
dose de  insulina  utilizada,  tempo  de  insulinizac¸ão  contínua,  volume  de  líquido  infundido  durante
o tratamento  e  complicac¸ões.
Métodos:  Estudo  descritivo  retrospectivo  com  revisão  de  prontuários  de  pacientes  interna-
dos na  UTI  pediátrica  de  um  hospital  de  referência  no  período  de  junho  de  2013  a  julho  de
2015. Analisamos  os  seguintes  dados  referentes  a  52  internac¸ões:  idade,  sexo,  peso,  super-
fície corporal,  sinais,  sintomas,  gravidade  na  admissão,  gasometrias,  glicemia,  hemoglobina
glicada, osmolaridade  sérica  e  índice  de  mortalidade.  As  crianc¸as  com  diabete  já  diagnosticado
foram comparadas  com  aquelas  sem  diagnóstico  prévio  quanto  à  dose  de  insulina,  tempo  de
insulinizac¸ão continua,  volume  infundido  na  fase  de  expansão  e  nas  primeiras  24  horas,  tempo
de internac¸ão  e  complicac¸ões  como  distúrbios  hidroeletrolíticos,  hipoglicemia,  edema  cerebral
e morte.
Resultados:  Os  pacientes  sem  diagnóstico  prévio  de  DM  I  eram  mais  jovens  no  momento  da
admissão,  com  média  de  idade  de  8,4  anos  (p  <  0,01).  Relataram  mais  sintomas  como  vômi-
tos, polidipsia  e  poliúria  e  apresentaram  mais  perda  de  peso  (p  <  0,01).  Observamos  maior
prevalência  de  hipocalemia  (p  <  0,01)  e  maior  tempo  de  internac¸ão  no  grupo  acima  citado.
Conclusões:  Não  observamos  diferenc¸as  quanto  a  gravidade  entre  os  grupos.  Pacientes  dia-
béticos prévios  eram  mais  jovens  na  admissão,  apresentaram  mais  hipocalemia  durante  o
tratamento  e  permaneceram  mais  tempo  internados.
© 2016  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´ um  artigo
Open Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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initial  blood  glucose  and  during  the  course  of  treatment,ntroduction
iabetic  ketoacidosis  (DKA)  is  a  potentially  severe  and  com-
on  condition  in  emergency  rooms  and  pediatric  intensive
are  units  (PICU).  It  is  one  of  the  major  complications  in
atients  with  type  1  diabetes  mellitus  (DM1).  In  Brazil,
pproximately  20%  of  patients  with  previously  undiagnosed
M1  initially  present  with  DKA.  It  is  more  common  in  children
nder  4  years  of  age  and  affects  10/100,000  children.1,2 As
 complication  in  children  already  diagnosed  with  DM1,  DKA
ccurs  in  1--10%  of  cases.2
Hospital  da  Crianc¸a Conceic¸ão  (HCC),  located  in  the  city
f  Porto  Alegre,  state  of  Rio  Grande  do  Sul,  Brazil,  is  a
eference  center  for  the  treatment  of  children  with  DM1.
atients  admitted  for  DKA  are  referred  for  treatment  in  the
ICU  of  the  institution,  and  after  the  initial  management
nd  resolution  of  acidosis,  they  are  followed  at  the  Outpa-
ient  Clinic  of  the  Institute  for  Children  with  Diabetes  (ICD).
lthough  it  is  a  reference  for  the  care  of  these  patients,  the
ervice  does  not  have  a  care  protocol.
DKA  treatment  has  been  widely  studied  and  described
n  the  literature;  however,  there  are  few  studies  comparing
he  clinical  characteristics  and  outcomes  between  patients
dmitted  for  DKA  with  previously  diagnosed  DM1  and  those
ith  no  prior  diagnosis  of  DM1.  The  objective  of  this  study
s  to  evaluate  the  characteristics  and  outcomes  of  patients
dmitted  for  DKA  in  the  intensive  care  unit  of  HCC,  com-
aring  the  following  variables  between  the  patient  with  a
M1  diagnosis  and  those  without  previous  diagnosis:  length
f  hospital  stay,  severity  on  admission,  prognostic  index
g
i
ﬁPediatric  Index  of  Mortality  II),  insulin  dose,  time  of  con-
inuous  insulin  use,  liquid  volume  infused  during  treatment,
nd  complications.
ethods
 descriptive,  retrospective  study  was  carried  out,  based  on
 review  of  medical  records  of  patients  with  DKA  diagnosis
dmitted  to  the  PICU  of  HCC,  Porto  Alegre,  from  June  2013
o  July  2015.  A  total  of  52  admissions  of  patients  aged
etween  zero  and  14  years  admitted  for  DKA  treatment  were
nalyzed.  DKA  diagnosis  was  deﬁned  according  to  the  crite-
ia  established  by  the  International  Society  for  Pediatric  and
dolescent  Diabetes  (ISPAD)  Consensus  of  2014:  venous  or
rterial  blood  gas  pH  <  7.3  and/or  bicarbonate  <15  mmol/L,
lucose  or  hemoglucotest  >200  mg/dL,  presence  of  ketone-
ia  or  ketonuria.3 Patients  with  other  diseases  in  addition
o  metabolic  acidosis  were  excluded.  DKA  cases  were
dentiﬁed  from  the  PICU  database.  Data  collection  was
erformed  using  a  standardized  tool  that  contained  the
ollowing  variables:  age,  gender,  weight,  body  surface  area,
nitial  diagnosis  of  DM1  or  previous  DM1,  signs  and  symptoms
n  admission,  blood  gas  data  (pH,  pCO2,  HCO3−,  BE)  on
dmission  and  after  withdrawal  of  continuous  insulin  use,
ime  of  continuous  insulin  use,  administered  insulin  dose,lycated  hemoglobin  levels,  serum  osmolality,  prognostic
ndex,  infused  volume  at  the  expansion  phase  and  in  the
rst  24  h  of  treatment,  and  complications  (hypoglycemia,
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hypercalcemia,  hypokalemia,  hyponatremia,  cerebral
edema,  and  death).
DKA  was  classiﬁed  as  mild  (pH  <  7.3  or  HCO3− <  15),  mod-
erate  (pH  <  7.2  and  HCO3− <  10),  or  severe  (pH  <  7.1  and
HCO3− <  5)  according  to  the  ISPAD  Consensus  of  2014.3
Hypoglycemia  was  deﬁned  as  blood  glucose  <  60  mg/dL,
hypokalemia  as  serum  potassium  <  3.5  mEq/L,4 hyper-
kalemia  as  serum  potassium  >  5.0  mEq/L,  hyponatremia  as
serum  sodium  <  135  mEq/L,4 uncorrected  by  blood  glucose
value.  Serum  osmolality  was  calculated  using  the  follow-
ing  formula:  [(2  ×  sodium)  +  (glucose/18)  +  (Urea/5.6)].4 The
prognostic  index  used  in  this  PICU  is  the  Pediatric  Index  of
Mortality  (PIM2).5
The  data  were  entered  into  an  Excel  spreadsheet  for
Windows  (Microsoft,  WA,  USA)  and  analyzed  using  the  SPSS
program,  version  22.0  (IBM  Corp.  Released  2013.  IBM  SPSS
Statistics  for  Windows,  Version  22.0.  NY,  USA).  Quantitative
variables  were  described  as  means  and  standard  deviations,
or  medians  and  interquartile  range  in  asymmetric  situations.
Categorical  variables  were  described  using  proportions  and
percentages.  The  nonparametric  tests  used  were  Fisher’s
exact  test  for  comparison  of  categorical  data  and  Stu-
dent’s  t-test  for  comparison  of  quantitative  variables,  or
the  Mann--Whitney  test  when  asymmetry  was  detected.  For
a
p
T
Table  1  Baseline  characteristics  of  patients.
Characteristic  Previous  DM1  n  =  21
Age,  years  11.8  ±  1.9  
Female gender,  n  (%)  13.0  (61.9)  
Weight, kg  42.3  ±  11.3  
BS, m2 1.29  ±  0.27  
Signs and  symptoms,  n  (%)
Nausea  or  vomiting  19.0  (90.5)  
Abdominal pain  7.0  (33.3)  
Polydipsia 0  
Polyuria 0  
Polyphagia 0  
Weight loss  0  
Tachypnea 5.0  (23.8)  
Fever 1.0  (4.8)  
Asthenia 3.0  (14.3)  
Drowsiness 2.0  (9.5)  
Severity, n  (%)  
Mild 3  (14.3)  
Moderate 12  (57.1)  
Severe 6  (28.6)  
PIM II 0.80  (0.40--1.85)  
Gasometry at  admission
pH  7.12  ±  0.13  
Bicarbonate,  (IQR)  mmol/mL  8.1  (4.6--11.9)  
pCO2,  mmHg  22.7  ±  9.2  
Glycemia at  admission,  mg/dL  431.7  ±  99.6  
HbA1C, %  10.8  ±  1.6  
Initial serum  osmolarity,  mOsm/L  303.0  ±  19.5  
Quantitative variables are expressed as mean ± standard deviation or m
DM1, type 1 diabetes mellitus; BS, body surface; PIM II, Pediatric Inde
hemoglobin. PRESS
3
djustments,  analysis  of  covariance  (ANCOVA)  was  used  for
uantitative  data.  Asymmetric  quantitative  data  received
ogarithmic  transformation.  The  adjustment  of  the  categori-
al  data  was  performed  through  logistic  regression.  The  level
f  signiﬁcance  was  set  at  ˛  =  0.05.  The  multivariate  analysis
sed  p  =  0.05  for  the  probability  of  inclusion  and  p  =  0.1  for
he  probability  of  exclusion.
This  study  was  approved  by  the  Institutional  Ethics  Com-
ittee.
esults
 total  of  52  admissions  were  analyzed,  corresponding  to
0  patients  who  were  admitted  to  the  PICU  of  HCC  during
 25-month  period.  Of  these,  26  were  females  and  two  re-
dmissions  were  also  female  patients;  one  of  the  patients
ad  a  previous  diagnosis  of  DM1  and  the  other  received  the
iagnosis  at  the  ﬁrst  hospital  admission.  For  purposes  of  data
nalysis,  the  number  displayed  corresponds  to  the  hospital
dmissions  and  not  to  the  number  of  patients.
The  mean  age  was  10.2  ±  2.9  years.  In  59.6%  of  the  hos-
ital  admissions,  patients  had  no  previous  diagnosis  of  DM1.
he  most  frequently  observed  symptoms  were  nausea  and
 Without  previous  DM1  n  =  31  p
8.4  ±  3.5  <0.001
15.0  (48.4)  0.4
29.6  ±  12.7  0.001
1.02  ±  0.32  0.001
13.0  (41.9)  <0.001
12.0  (38.7)  0.77
23.0  (74.2)  --
23.0  (74.2)  --
4.0  (12.9)  --
25.0  (80.6)  --
5.0  (16.1)  0.5
1.0  (3.2)  --
6.0  (19.4)  0.72
5.0  (16.1)  0.68
0.49
7  (22.6)  --
12  (38.7)  --
12  (38.7)  --
1.10  (0.70--2.80)  0.27
7.13  ±  0.14  0.95
7.0  (3.7--10.2)  0.39
19.9  ±  8.2  0.27
456.8  ±  127.5  0.43
11.8  ±  1.6  0.07
305.0  ±  13.8  0.63
edian and interquartile range.
x of Mortality II; IQR, interquartile range; HbA1C%, glycosylated
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Table  2  Outcomes.
Previous  DM1
n  =  21
Without  previous
DM1  n  =  31
p  pa
Insulin  dose,  IU/kg/h 0.090  ±  0.023 0.080  ±  0.019 0.45  0.21
Time of  insulin  use  (IQR),  h  11.0  (7.0--19.0)  16.0  (7.7--19.5)  0.57  0.82
IV volume  (IQR)
Expansion,  mL/kg  41.7  (26.0--81.8)  55.6  (37.5--82.5)  0.23  0.52
First 24  h,  mL/m2 3644  (1845--4449)  3585  (2525--4763)  0.61  0.89
Electrolyte disturbances,  n  (%)  15.0  (71.4)  24.0  (77.4)  0.75  0.60
Hyponatremia  10.0  (47.6)  13.0  (41.9)  0.77  0.85
Hyperkalemia  8.0  (38.1)  5.0  (16.1)  0.1  0.07
Hypokalemia  3.0  (14.3)  15.0  (48.4)  0.017  0.03
Hypoglycemia,  n  (%)  1.0  (4.8)  7.0  (22.6)  0.12  0.53
Length of  hospital  stay  (IQR),  h  34  (24--54)  50  (38--70)  0.02  0.06
Death, n  (%)  0  1  >0.99  --
Gasometry at  CI  withdrawal
pH  7.34  ±  0.02  7.33  ±  0.05  0.85  0.44
Bicarbonate,  mmoL/mL  17.9  ±  3.4  16.5  ±  1.7  0.88  0.07
pCO2,  mmHg 31.7  ±  4.8  31.3  ±  5.1  0.77  0.70
Cerebral edema  treatment,  n  (%)  1.0  (4.8)  2.0  (6.5)  >0.99  --
Quantitative variables are expressed as mean ± standard deviation or median and interquartile range.
IM II
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a Statistical signiﬁcance adjusted for age, gender, severity of DK
omiting,  followed  by  weight  loss,  polyuria,  and  polydipsia.
atients  less  frequently  reported  abdominal  pain,  asthenia,
omnolence,  tachypnea,  and  polyphagia.
It  was  observed  that  children  with  no  prior  diagnosis
f  DM1  were  younger  at  the  time  of  hospital  admission
nd  more  frequently  had  polydipsia,  polyuria,  and  weight
oss,  whereas  patients  who  already  had  a  diagnosis  of  DM1
ore  frequently  experienced  vomiting  as  the  most  preva-
ent  symptom.  Table  1  shows  the  comparison  between  the
asal  characteristics  of  the  two  groups.
When  the  groups  were  compared  regarding  outcomes,  no
tatistically  signiﬁcant  difference  were  found  with  regard  to
nsulin  dose  and  time  of  continuous  insulin  use,  severity  at
dmission,  intravenous  volume  administered  in  the  expan-
ion  phase  and  in  the  ﬁrst  24  h,  and  hypoglycemia  (Table  2).
lso,  there  was  no  statistically  signiﬁcant  difference  in
he  number  of  patients  who  required  treatment  for  cere-
ral  edema.  The  prevalence  of  electrolyte  disturbances  was
imilar  between  the  two  groups;  however,  when  analyzed
eparately,  hypokalemia  was  more  frequent  in  the  group
f  patients  with  no  previous  diagnosis  of  DM1  (p  =  0.017).
atients  who  did  not  know  they  were  diabetics  also  had
reater  length  of  hospital  stay,  with  a  mean  of  50  h  (p  =  0.02).
here  was  one  death  in  the  group  of  patients  with  no  prior
iagnosis  of  DM1  and  the  cause  of  death  was  cerebral  edema.
iscussionospital  admissions  for  DKA  account  for  approximately  5%
f  hospitalizations  each  year  in  this  service.  The  worldwide
ncidence  of  DM1  ranges  from  0.1  to  36.8  cases  per  100,000
nhabitants  per  year  and,  despite  the  educational  programs
l
t
0
o, Pediatric Index of Mortality II; CI, continuous insulin.
d PIM II.
nd  the  numerous  studies  on  the  subject,  mortality  from
KA  has  remained  around  1--2%  since  1970.2
The  present  study  included  52  admissions,  correspond-
ng  to  50  patients.  Of  these,  40.4%  had  a  previous  diagnosis
f  DM1.  The  mean  age  of  admission  was  11.8  years,  which
emonstrates  the  importance  of  parental  involvement  in  the
reatment  of  their  children  and  in  educational  programs.
As  for  the  symptoms  at  admission,  the  most  frequent
ere  nausea  and  vomiting.  Patients  who  did  not  know  they
ere  diabetics  more  often  had  records  in  their  medical  ﬁles
f  the  classic  symptoms  of  DM1,  such  as  polydipsia,  polyuria,
nd  weight  loss.  These  ﬁndings  were  not  observed  in  other
tudies.3,6 This  may  have  occurred  because  the  patients  who
ere  already  using  insulin  had  more  acute  clinical  decom-
ensation,  due  to  the  inappropriate  use  of  medication  or  due
o  the  more  objective  medical  approach  when  a  diagnosis  of
M1  had  already  been  established.7
The  most  frequently  used  continuous  insulin  dose  in  this
ample  was  0.1  IU/kg/min,  the  same  dose  recommended
n  the  last  consensus  on  DKA  treatment.3,8--10 It  is  consid-
red  a  low  dose,  but  one  that  achieves  high  physiological
oncentrations,  with  complete  inhibition  of  lipolysis  and
etogenesis,  complete  suppression  of  liver  glucose  produc-
ion,  and  almost  total  tissue  use  of  glucose,  except  in
ituations  of  insulin  resistance.11,12 Some  recent  research
as  compared  the  normally  recommended  dose  with  insulin
nfusion  of  0.05  IU/kg/h.  An  observational  study  suggested
hat  the  dose  of  0.05  IU/kg/h  was  as  effective  as  the  dose
f  0.1  IU/kg/h  in  the  treatment  of  93  DKA  episodes,  at
east  in  the  initial  6  h  of  treatment.13 Another  retrospec-
ive  study  comparing  33  children  who  used  the  dose  of
.05  IU/kg/h  with  34  children  who  received  insulin  at  a  dose
f  0.1  IU/kg/h  suggested  that  treatment  with  lower  doses
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of  insulin  can  be  safe,  promoting  a  more  gradual  reduction
in  serum  osmolality  and,  thus,  reducing  the  risk  of  cerebral
edema.11 Analysis  of  the  present  study  showed  no  difference
between  the  two  groups  regarding  the  administered  insulin
dose.
A  study  comparing  117  children  hospitalized  for  DKA  in
a  hospital  in  Pakistan  showed  a  longer  continuous  time  of
insulin  use  in  patients  that  had  no  diagnosis  of  DM1  at  admis-
sion.  However,  these  patients  were  categorized  as  being
more  severe.14 A  study  in  Campinas,  state  of  Sao  Paulo,
Brazil,  showed  that  the  time  of  continuous  insulin  use  was
directly  proportional  to  laboratory  abnormalities  and,  thus,
to  DKA  severity.2 The  time  of  continuous  insulin  use  in  the
present  study  was  slightly  longer  in  patients  who  had  no
diagnosis  of  DM1  prior  to  the  DKA  episode,  but  there  was
no  statistically  signiﬁcant  difference.
When  the  outcome  electrolyte  disturbance  was  evalu-
ated,  the  groups  showed  no  difference;  however,  when  each
disorder  was  analyzed  separately,  hypokalemia  was  signiﬁ-
cantly  more  frequent  in  patients  without  a  prior  diagnosis  of
DM1.  An  international  study  showed  no  difference  between
groups  when  hypokalemia  was  evaluated  as  a  complication
of  treatment.14 In  another  study,  in  which  most  of  the  chil-
dren  had  DKA  as  the  ﬁrst  manifestation  of  DM1,  hypokalemia
was  detected  in  41%  of  cases  during  treatment.15 The  chil-
dren  with  DKA  have  a  total  body  deﬁcit  of  potassium  of
around  3--6  mmol/kg.8 Potassium  is  usually  lost  as  a  result
of  vomiting,  osmotic  diuresis,  and  hyperaldosteronism  sec-
ondary  to  volume  depletion,  which  also  promotes  urinary
excretion  of  potassium.  Insulin  administration  and  acidosis
correction  cause  potassium  to  be  diverted  to  the  intracellu-
lar  environment,  further  decreasing  serum  levels  of  this  ion,
which  may  predispose  to  arrhythmias.4,8
For  the  authors,  a  possible  reason  why  the  children  with
no  diagnosis  of  DM1  had  higher  hypokalemia  might  have
been  the  fact  that  they  were  exposed  to  the  abovemen-
tioned  pathophysiological  mechanisms  for  a  longer  period
of  time,  with  a  more  depleted  total  body  potassium  in  rela-
tion  to  children  already  undergoing  treatment  for  DM1.  More
studies  are  needed  to  conﬁrm  this  ﬁnding.
Hypoglycemia  as  a  complication  of  treatment  occurred  in
15%  of  hospitalizations,  which  is  similar  to  other  studies.14,15
When  the  two  groups  were  compared,  children  without  DM1
had  more  hypoglycemia,  but  this  ﬁnding  was  not  statistically
signiﬁcant  and  variations  in  glucose  input  used  in  this  service
can  probably  explain  this  fact.
Regarding  length  of  hospital  stay,  this  study  showed  that
patients  without  a  previous  diagnosis  of  DM1  remained  in
the  PICU  for  a  longer  period  of  time,  as  was  also  observed
in  a  study  carried  out  in  Pakistan.14 This  can  be  explained
by  the  fact  that  these  patients  often  require  more  time  for
insulin  dose  adjustment  and  for  the  family  to  get  used  to  the
treatment.
As  greater  severity  was  not  observed  in  patients  without
a  previous  diagnosis  of  DM1,  nor  a  statistically  signiﬁcant
difference  in  time  of  insulin  use,  these  factors  do  not  seem
to  have  inﬂuenced  the  length  of  hospital  stay.
In  this  study,  three  patients  received  treatment  for  cere-
bral  edema  (hypertonic  saline  solution  or  mannitol),  which
corresponds  to  5.7%  of  the  study  population.  The  literature
describes  an  incidence  of  0.5--1%  of  cerebral  edema  due  to
DKA;  however,  changes  in  the  mental  status  with  Glasgow PRESS
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oma  Scale  score  <14  occur  in  approximately  15%  of  chil-
ren  treated  for  DKA  and  are  associated  with  evidence  of
erebral  edema  in  imaging  studies.3,8 Taking  these  data  into
ccount,  it  can  be  considered  that  this  sample  follows  the
atterns  reported  in  other  studies.
It  is  possible  that  more  patients  showed  some  degree
f  cerebral  edema,  characterized  by  symptoms  such  as
eadache,  drowsiness,  vomiting,  and  lethargy.  As  this  study
as  based  on  chart  review,  the  data  may  have  been  lost,
ecause  clinical  symptoms  are  frequently  not  recorded  in
he  medical  ﬁles.
There  was  no  statistically  signiﬁcant  difference  in  the
ncidence  of  cerebral  edema  between  the  two  groups,  which
as  expected,  since  ketoacidosis  severity  at  admission  and
he  amount  of  administered  volume  were  similar.  There  is
vidence  that  more  severe  dehydration  and  refractory  shock
re  risk  factors  for  development  of  cerebral  edema.16
The  present  study  shows  the  high  prevalence  of  hospital-
zations  due  to  DKA  in  this  service;  this  fact  indicates  the
eed  for  public  awareness  about  the  symptoms,  as  well  as
he  importance  of  family  involvement  in  the  management
f  these  patients.
This  PICU  does  not  have  a  treatment  protocol  for  DKA
ases,  which  makes  the  management  heterogeneous,  possi-
ly  inﬂuencing  the  observed  clinical  outcomes.  This  was  a
etrospective  study,  no  trigger  factors  were  identiﬁed,  and
he  sample  size  was  small,  a  limitation.
It  was  concluded  that  there  were  no  differences  in  sever-
ty  between  the  groups.  Patients  with  a  prior  DM1  diagnosis
ere  younger  at  admission,  had  more  hypokalemia  during
reatment,  and  had  greater  length  of  hospital  stay.  Fur-
her  studies  are  needed  to  perform  a  better  epidemiological
ssessment  of  these  groups.
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